Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of blood in the laboratory from young patients with cancer may
help doctors learn how carboplatin, cyclophosphamide, and etoposide affect the body and how
patients will respond to treatment.
PURPOSE: This laboratory study is evaluating the side effects and how well anticancer drugs
work in very young patients with cancer.